AgeX Therapeutics Inc.

AMEX: AGE · Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.21M -14.81M -10.52M -8.58M
Depreciation & Amortization
194K 131K 132K 131K
Stock-Based Compensation
2.6M 648K 760K 999K
Other Working Capital
n/a n/a 164K -112K
Other Non-Cash Items
n/a 6.7M 3.36M 1.11M
Deferred Income Tax
n/a -1.1M n/a -633K
Change in Working Capital
n/a 625K 329K -884K
Operating Cash Flow
-17.14M -7.8M -5.94M -7.86M
Capital Expenditures
-22K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a 466K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -10M n/a 200K
Investing Cash Flow
-22K -10M n/a 666K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.25M 17.5M 6M 7.25M
Financial Cash Flow
13.21M 17.5M 6M 7.25M
Net Cash Flow
n/a -300K 61K 57K
Free Cash Flow
-17.16M -7.8M -5.94M -7.86M